Dr. Karin Denton:

One of my other concerns is that, unfortunately, women who are due to have a sample taken and are at greater risk than those who have been tested, possibly quite recently, are also getting stuck in the backlog. It is, therefore, disproportionately disadvantaging those who are due to have a test. That includes the women we really want to engage in the screening programme, those other than “the worried well”. It is not for us to say what action should be taken. All I can do is point out that the current volume is unsustainable.